Mutation Detection and Its Applications in Medicine

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Gene and Cell Therapy".

Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 430

Special Issue Editors


E-Mail Website
Guest Editor
Division of Laboratory Medicine, Asia University Hospital, Taichung, Taiwan Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan
Interests: laboratory medicine; molecular medicine; molecular diagnostics; oncology; cancer genetics
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan
Interests: protein structure; structure prediction; molecular dynamics; structural bioinformatics; colorectal cancer

Special Issue Information

Dear Colleagues,

Mutation detection plays an important role in all areas of biology. Thus far, many different methods, especially high-throughput sequencing technologies, have been developed to identify disease-causing mutations. Additionally, these methods may be applied to the early detection and prognosis of certain diseases. Moreover, the discovery of disease-causing mutations can be used to elucidate the underlying molecular mechanisms of diseases.

Potential researchers are invited to submit their work on mutation detection and its application in medicine. Papers on the development of mutation detection techniques for identifying disease-causing mutations are particularly welcome.

Dr. Tze-Kiong Er
Dr. Chih-Chieh Chen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mutation
  • detection
  • molecular techniques
  • molecular analysis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop